Lv4
700 积分 2023-01-16 加入
From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases
3个月前
已完结
Structural insight into selectivity of amylin and calcitonin receptor agonists
6个月前
已完结
Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2– Breast Cancer
6个月前
已完结
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
7个月前
已完结
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
7个月前
已完结
Identification of triazolyl KAT6 inhibitors via a templated fragment approach
8个月前
已完结
Design of a Cereblon construct for crystallographic and biophysical studies of protein degraders
8个月前
已完结
Plasticity in binding confers selectivity in ligand-induced protein degradation
8个月前
已完结
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction
1年前
已完结
Molecular glues that facilitate RAS binding to PI3Kα promote glucose uptake without insulin
1年前
已完结
皖公网安备34019202002308
